Findings

What do systematic reviews say?

4,730 questions · 18,059 findings · 1,282 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 4,360 · 24.1%GRADE not reported 2,529 · 14%Very low 4,641 · 25.7%Low 4,007 · 22.2%Moderate 2,057 · 11.4%High 465 · 2.6%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Prophylactic dopamine antagonist antiemetic medications vs placebo

Nausea severity · adults receiving intravenous opioids

1 finding from 1 review

Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 191 participants
Low

Cervical pessary vs vaginal progesterone

Harm to offspring from the intervention · women with singleton pregnancies at risk of cervical insufficiency

1 finding from 1 review

Cervical pessary for preventing preterm birth in singleton pregnancies 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 11 participants
Low

Cervical pessary vs cervical cerclage

Harm to offspring from the intervention · women with singleton pregnancies at risk of cervical insufficiency

1 finding from 1 review

Cervical pessary for preventing preterm birth in singleton pregnancies 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 13 participants
Low

Cervical pessary vs no treatment

Harm to offspring from the intervention · women with singleton pregnancies at risk of cervical insufficiency

The review found no eligible studies for this question.

1 finding from 1 review

Cervical pessary for preventing preterm birth in singleton pregnancies 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Continuous vs intermittent bolus (nasogastric and orogastric tube) milk feeding ‐ all preterm infants less than 1500 grams

Rate of weight gain (g/kg/day) · preterm infants less than 1500 grams

1 finding from 1 review

Continuous nasogastric milk feeding versus intermittent bolus milk feeding for preterm infants less than 1500 grams 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 433 participants
Very low

Continuous vs intermittent bolus (nasogastric and orogastric tube) milk feeding ‐ all preterm infants less than 1500 grams

End of intervention: rate of gain in length (cm/week) · preterm infants less than 1500 grams

1 finding from 1 review

Continuous nasogastric milk feeding versus intermittent bolus milk feeding for preterm infants less than 1500 grams 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 433 participants
Low

Continuous vs intermittent bolus (nasogastric and orogastric tube) milk feeding ‐ all preterm infants less than 1500 grams

Growth: head circumference (cm/week) · preterm infants less than 1500 grams

1 finding from 1 review

Continuous nasogastric milk feeding versus intermittent bolus milk feeding for preterm infants less than 1500 grams 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 433 participants
Low

Dipyridamole vs placebo

Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous graft

The review found no eligible studies for this question.

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Dipyridamole plus aspirin vs placebo

Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous graft

The review found no eligible studies for this question.

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Warfarin vs placebo

Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous graft

The review found no eligible studies for this question.

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Fish oil vs placebo

Radiological or surgical intervention (up to 12 months) · people with ESRD receiving haemodialysis through an arteriovenous graft

Fish oil showed no clear difference in radiological or surgical intervention (up to 12 months) compared with placebo (moderate certainty).

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
OR 0.64 [0.36, 1.12]
1 study · 196 participants
Moderate

Clopidogrel vs placebo

Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula

Clopidogrel showed no clear difference in number of related surgical or radiological interventions (42 days) compared with placebo (moderate certainty).

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
OR 0.69 [0.26, 1.82]
1 study · 866 participants
Moderate

Sulphinpyrazone vs placebo

Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft

The review found no eligible studies for this question.

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Glyceryl trinitrate patch vs placebo

Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula

The review found no eligible studies for this question.

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Aspirin vs placebo

Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft

The review found no eligible studies for this question.

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ticlopidine vs placebo

Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft

The review found no eligible studies for this question.

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Further surgical or laser interventions · adults with PACS or PAC, and previous PI

The review found no eligible studies for this question.

1 finding from 1 review

Laser peripheral iridoplasty for chronic angle closure 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Further surgical or laser interventions · adults with PAC or PACG, and previous PI

1 finding from 1 review

Laser peripheral iridoplasty for chronic angle closure 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low

Intervention not reported

Further surgical or laser interventions · adults with PACS, PAC or PACG

1 finding from 1 review

Laser peripheral iridoplasty for chronic angle closure 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 126 participants
Low

Propionyl‐L‐carnitine vs L‐carnitine

Progression of disease (to Fontaine stage III or IV or necessity for intervention (endovascular or surgery)) · intermittent claudication

The review found no eligible studies for this question.

1 finding from 1 review

Propionyl‐L‐carnitine for intermittent claudication 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found